Ga
Galena Biopharma
Portland ORFounded 200620 employees
Private CapbiotechAcquiredOncology
Platform: NeuVax BC
Market Cap
N/A
All Drugs
4
Clinical Trials
10
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GAL-555 | GAL-555 | Phase 3 | 4 | C5 | UCPsoriasis | ||
| Zenotuximab | GAL-8107 | Phase 1/2 | 2 | TNFα | RCC | ||
| Capitapinarof | GAL-2731 | Preclinical | 2 | KIF18A | Cholangiocarcinoma | ||
| GAL-3172 | GAL-3172 | Preclinical | 2 | CFTR | CKDCML |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (7)